Page last updated: 2024-08-17

carbostyril and Glioma

carbostyril has been researched along with Glioma in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's6 (50.00)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annunziata, P; Cioni, C; Corelli, F; Marotta, G; Mugnaini, C; Tassi, M1
Boyett, JM; Geyer, R; Haas-Kogan, D; Kieran, MW; Kun, L; Ng, S; Pollack, IF; Poussaint, TY; Prabhu, SP; Vajapeyam, S1
Boyett, JM; Cha, S; Geyer, R; Haas-Kogan, D; Kocak, M; Kun, LE; Packer, RI; Patay, Z; Pollack, IF; Poussaint, TY; Robertson, RL; Vajapeyam, S; Vezina, G; Zimmerman, R1
Alauddin, MM; Gelovani, JG; Ivanov, RA; Rabinovich, B; Shavrin, A; Turkman, N; Volgin, A1
Nowakowski, A; Petering, D1
Bonnet, J; Cohen-Jonathan, E; Delmas, C; End, D; Favre, G; Heliez, C; Toulas, C1
Cohen-Jonathan, E; Delmas, C; End, D; Favre, G; Rochaix, P; Toulas, C1
Abrey, L; Chang, S; Cloughesy, TF; DeAngelis, L; Fink, K; Groves, M; Junck, L; Kuhn, J; Lamborn, K; Lieberman, FS; Mehta, M; Paquette, S; Prados, M; Robins, HI; Schiff, D; Sebti, SM; Wen, P; Wright, J; Yung, A1
Abrey, L; Aldape, K; Chang, SM; Cloughesy, TF; DeAngelis, LM; Fink, KL; Gilbert, MR; Groves, MD; Junck, L; Kuhn, J; Lamborn, KR; Lieberman, F; Mehta, M; Prados, MD; Raizer, JJ; Robins, HI; Schiff, D; Wen, PY; Wright, J; Yung, WK1
Cohen, K; Fouladi, M; Helton, KJ; Holmes, E; Laningham, F; Nicholson, HS; Pollack, IF; Speights, RA; Wright, J; Zhou, T1
Banerjee, A; Blaney, SM; Boyett, JM; Broniscer, A; Fouladi, M; Geyer, JR; Haas-Kogan, DA; Kocak, M; Kun, LE; McKnight, T; Poussaint, TY; Prados, MD1
Gonzalez, AM; Jiang, D; Lawler, CP; Lewis, MM; Mailman, RB; Mak, C; Prioleau, C; Schetz, JA; Sibley, DR1

Trials

4 trial(s) available for carbostyril and Glioma

ArticleYear
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-20, Volume: 23, Issue:27

    Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Quinolones; Risk Assessment; Salvage Therapy; Survival Analysis; Treatment Outcome

2005
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-01, Volume: 24, Issue:22

    Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Drug Administration Schedule; Enzyme Induction; Epilepsy; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; North America; Quinolones; Treatment Outcome

2006
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
    Cancer, 2007, Dec-01, Volume: 110, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Female; Glioma; Humans; Male; Medulloblastoma; Neuroectodermal Tumors; Quinolones; Treatment Outcome

2007
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Neuro-oncology, 2008, Volume: 10, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Quinolones; Radiotherapy

2008

Other Studies

8 other study(ies) available for carbostyril and Glioma

ArticleYear
A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
    Central nervous system agents in medicinal chemistry, 2019, Volume: 19, Issue:3

    Topics: Adamantane; Apoptosis; Cannabinoid Receptor Agonists; Cannabinoids; Cell Proliferation; Dose-Response Relationship, Drug; Glioma; Humans; Quinolones; Receptor, Cannabinoid, CB2; Transforming Growth Factor beta; Tumor Cells, Cultured

2019
DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2011, Volume: 27, Issue:1

    Topics: Adolescent; Anisotropy; Antineoplastic Agents; Brain Stem; Brain Stem Neoplasms; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Diffusion Tensor Imaging; Gefitinib; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Nerve Fibers, Myelinated; Quinazolines; Quinolones; Radiotherapy

2011
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
    Neuro-oncology, 2011, Volume: 13, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Diffusion; Female; Gefitinib; Glioma; Humans; Magnetic Resonance Imaging; Male; Quinazolines; Quinolones; Radiotherapy Dosage; Research Design; Survival Rate; Treatment Outcome

2011
Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.
    Bioorganic & medicinal chemistry, 2011, Sep-15, Volume: 19, Issue:18

    Topics: Binding, Competitive; Cell Line, Tumor; Dose-Response Relationship, Drug; Glioma; Humans; Ligands; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship

2011
Sensor specific imaging of proteomic Zn2+ with zinquin and TSQ after cellular exposure to N-ethylmaleimide.
    Metallomics : integrated biometal science, 2012, Volume: 4, Issue:5

    Topics: Aminoquinolines; Animals; Cell Line, Tumor; Cytoplasmic Structures; Ethylmaleimide; Fluorescent Dyes; Glioma; Proteome; Proteomics; Quinolones; Rats; Spectrometry, Fluorescence; Sulfhydryl Compounds; Tosyl Compounds

2012
Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation.
    International journal of cancer, 2002, Jul-01, Volume: 100, Issue:1

    Topics: Alkyl and Aryl Transferases; Cell Death; Cell Survival; Enzyme Inhibitors; Farnesyltranstransferase; Gene Expression; Genes, ras; Glioma; Humans; Mutation; Quinolones; Radiation-Sensitizing Agents; ras Proteins; rhoB GTP-Binding Protein; Transfection; Tumor Cells, Cultured

2002
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-01, Volume: 9, Issue:16 Pt 1

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Cell Hypoxia; Enzyme Inhibitors; Farnesyltranstransferase; Glioblastoma; Glioma; Humans; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Oxygen; Quinolones; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 20, Issue:6

    Topics: Animals; Antipsychotic Agents; Aripiprazole; CHO Cells; Corpus Striatum; Cricetinae; Glioma; Piperazines; Quinolones; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Tumor Cells, Cultured

1999